Evidence map›Paper›PMID 31488582›Full record

ArticleThe Journal of cell biology2019

New factors for protein transport identified by a genome-wide CRISPRi screen in mammalian cells.

Laia Bassaganyas, Stephanie J Popa, Max Horlbeck, Claudia Puri, Sarah E Stewart, Felix Campelo, Anupama Ashok, Cristian M Butnaru, Nathalie Brouwers, Kartoosh Heydari and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of cell biology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
1.3field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 42 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Sending out molecules from the TGN.Current opinion in cell biology · 2021
    Review
  15. Article
  16. Article
  17. Article
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 8 institutions in 5 countries.

Laia BassaganyasDepartment of Medical Genetics, National Institute for Health Research Cambridge Biomedical Research Centre, and Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, UK.ORCID 0000-0002-4575-0214
Stephanie J PopaUniversity of Cambridge Metabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID 0000-0002-3424-4674
Max HorlbeckDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA.ORCID 0000-0002-3875-871X
Claudia PuriDepartment of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID 0000-0001-7080-9938
Sarah E StewartUniversity of Cambridge Metabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.ORCID 0000-0003-3712-9898
Felix CampeloInstitut de Ciencies Fotoniques, Barcelona Institute of Science and Technology, Castelldefels, Spain.ORCID 0000-0002-0786-9548
Anupama AshokCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Cristian M ButnaruCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.
Nathalie BrouwersCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID 0000-0002-9808-9394
Kartoosh HeydariCell Therapy Facility, Stanford Health Care, Stanford, CA.
Jean RipocheInstitut National de la Sante et de la Recherche Medicale U1026, Université de Bordeaux, Bordeaux, France.
Jonathan WeissmanDepartment of Cellular and Molecular Pharmacology, University of California, San Francisco, San Francisco, CA.
David C RubinszteinDepartment of Medical Genetics, Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK.ORCID 0000-0001-5002-5263
Randy SchekmanDepartment of Molecular and Cell Biology, Howard Hughes Medical Institute, University of California, Berkeley, Berkeley, CA.ORCID 0000-0001-8615-6409
Vivek MalhotraCentre for Genomic Regulation, Barcelona Institute of Science and Technology, Barcelona, Spain.ORCID 0000-0001-6198-7943
Kevin Moreau *University of Cambridge Metabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK.
Julien Villeneuve *University of Cambridge Metabolic Research Laboratories, Wellcome Trust-Medical Research Council Institute of Metabolic Science, University of Cambridge, Cambridge, UK julienvilleneuve81@gmail.com.ORCID 0000-0002-5430-1680
University of Cambridge · GBCentre for Genomic Regulation · ESUniversity of California, San Francisco · USHoward Hughes Medical Institute · USInstitute of Photonic Sciences · ESNational Institute for Laser Plasma and Radiation Physics · ROStanford Health Care · USUniversité de Bordeaux · FR

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007618 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI ANDERSON, MARK S · 1985 to 2020
$29.6M
Integrative Program in Complex Biological System (ipCBS)T32EB009383 · NIBIB · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MARSHALL, WALLACE, WEINER, ORION D · 2009 to 2022
$3.2M
Biotechnology and Biological Sciences Research Council BB/P010911/1Medical Research Council MC_UU_12012/5Medical Research Council UKDRI-2002NIBIB NIH HHS T32 EB009383NIGMS NIH HHS T32 GM007618Wellcome TrustWellcome Trust 109152/Z/15/Z
6 · The paper itself

Abstract

Protein and membrane trafficking pathways are critical for cell and tissue homeostasis. Traditional genetic and biochemical approaches have shed light on basic principles underlying these processes. However, the list of factors required for secretory pathway function remains incomplete, and mechanisms involved in their adaptation poorly understood. Here, we present a powerful strategy based on a pooled genome-wide CRISPRi screen that allowed the identification of new factors involved in protein transport. Two newly identified factors, TTC17 and CCDC157, localized along the secretory pathway and were found to interact with resident proteins of ER-Golgi membranes. In addition, we uncovered that upon TTC17 knockdown, the polarized organization of Golgi cisternae was altered, creating glycosylation defects, and that CCDC157 is an important factor for the fusion of transport carriers to Golgi membranes. In conclusion, our work identified and characterized new actors in the mechanisms of protein transport and secretion and opens stimulating perspectives for the use of our platform in physiological and pathological contexts.

Indexed as

Carrier ProteinsCell Cycle ProteinsCells, CulturedClustered Regularly Interspaced Short Palindromic RepeatsGolgi ApparatusHEK293 CellsHeLa CellsHumansCarrier ProteinsCell Cycle Proteinstetratricopeptide repeat protein 17, human

Identifiers

PMID31488582
PMCPMC6829651
OpenAlexW2971707555

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-SA
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.